162 related articles for article (PubMed ID: 20600720)
1. Synthesis and in vitro evaluation of potential sustained release prodrugs via targeting ASBT.
Zheng X; Polli JE
Int J Pharm; 2010 Aug; 396(1-2):111-8. PubMed ID: 20600720
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and in vitro evaluation of gabapentin prodrugs that target the human apical sodium-dependent bile acid transporter (hASBT).
Rais R; Fletcher S; Polli JE
J Pharm Sci; 2011 Mar; 100(3):1184-95. PubMed ID: 20848648
[TBL] [Abstract][Full Text] [Related]
3. Green tea catechin EGCG inhibits ileal apical sodium bile acid transporter ASBT.
Annaba F; Kumar P; Dudeja AK; Saksena S; Gill RK; Alrefai WA
Am J Physiol Gastrointest Liver Physiol; 2010 Mar; 298(3):G467-73. PubMed ID: 20056894
[TBL] [Abstract][Full Text] [Related]
4. Interaction of native bile acids with human apical sodium-dependent bile acid transporter (hASBT): influence of steroidal hydroxylation pattern and C-24 conjugation.
Balakrishnan A; Wring SA; Polli JE
Pharm Res; 2006 Jul; 23(7):1451-9. PubMed ID: 16783481
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and in vitro evaluation of bile acid prodrugs of floxuridine to target the liver.
Vivian D; Polli JE
Int J Pharm; 2014 Nov; 475(1-2):597-604. PubMed ID: 25219859
[TBL] [Abstract][Full Text] [Related]
6. Structural requirements of bile acid transporters: C-3 and C-7 modifications of steroidal hydroxyl groups.
Kolhatkar V; Polli JE
Eur J Pharm Sci; 2012 May; 46(1-2):86-99. PubMed ID: 22387310
[TBL] [Abstract][Full Text] [Related]
7. Structural requirements of the ASBT by 3D-QSAR analysis using aminopyridine conjugates of chenodeoxycholic acid.
Zheng X; Pan Y; Acharya C; Swaan PW; Polli JE
Bioconjug Chem; 2010 Nov; 21(11):2038-48. PubMed ID: 20968316
[TBL] [Abstract][Full Text] [Related]
8. Development of stably transfected monolayer overexpressing the human apical sodium-dependent bile acid transporter (hASBT).
Balakrishnan A; Sussman DJ; Polli JE
Pharm Res; 2005 Aug; 22(8):1269-80. PubMed ID: 16078136
[TBL] [Abstract][Full Text] [Related]
9. Apical sodium-dependent bile acid transporter, drug target for bile acid related diseases and delivery target for prodrugs: Current and future challenges.
Li M; Wang Q; Li Y; Cao S; Zhang Y; Wang Z; Liu G; Li J; Gu B
Pharmacol Ther; 2020 Aug; 212():107539. PubMed ID: 32201314
[TBL] [Abstract][Full Text] [Related]
10. Modulation of ileal bile acid transporter (ASBT) activity by depletion of plasma membrane cholesterol: association with lipid rafts.
Annaba F; Sarwar Z; Kumar P; Saksena S; Turner JR; Dudeja PK; Gill RK; Alrefai WA
Am J Physiol Gastrointest Liver Physiol; 2008 Feb; 294(2):G489-97. PubMed ID: 18063707
[TBL] [Abstract][Full Text] [Related]
11. Cholesterol modulates human intestinal sodium-dependent bile acid transporter.
Alrefai WA; Sarwar Z; Tyagi S; Saksena S; Dudeja PK; Gill RK
Am J Physiol Gastrointest Liver Physiol; 2005 May; 288(5):G978-85. PubMed ID: 15604201
[TBL] [Abstract][Full Text] [Related]
12. Modulation of ileal apical Na+-dependent bile acid transporter ASBT by protein kinase C.
Sarwar Z; Annaba F; Dwivedi A; Saksena S; Gill RK; Alrefai WA
Am J Physiol Gastrointest Liver Physiol; 2009 Sep; 297(3):G532-8. PubMed ID: 19571234
[TBL] [Abstract][Full Text] [Related]
13. Bile acid-induced negative feedback regulation of the human ileal bile acid transporter.
Neimark E; Chen F; Li X; Shneider BL
Hepatology; 2004 Jul; 40(1):149-56. PubMed ID: 15239098
[TBL] [Abstract][Full Text] [Related]
14. Apical sodium dependent bile acid transporter (ASBT, SLC10A2): a potential prodrug target.
Balakrishnan A; Polli JE
Mol Pharm; 2006; 3(3):223-30. PubMed ID: 16749855
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of cholangiocyte and ileal bile acid transporters following bile acid supplementation and depletion.
Kip NS; Lazaridis KN; Masyuk AI; Splinter PL; Huebert RC; LaRusso NF
World J Gastroenterol; 2004 May; 10(10):1440-6. PubMed ID: 15133850
[TBL] [Abstract][Full Text] [Related]
16. Glucuronidation converting methyl 1-(3,4-dimethoxyphenyl)-3-(3-ethylvaleryl)-4-hydroxy-6,7,8-trimethoxy-2-naphthoate (S-8921) to a potent apical sodium-dependent bile acid transporter inhibitor, resulting in a hypocholesterolemic action.
Sakamoto S; Kusuhara H; Miyata K; Shimaoka H; Kanazu T; Matsuo Y; Nomura K; Okamura N; Hara S; Horie K; Baba T; Sugiyama Y
J Pharmacol Exp Ther; 2007 Aug; 322(2):610-8. PubMed ID: 17470645
[TBL] [Abstract][Full Text] [Related]
17. Transactivation of rat apical sodium-dependent bile acid transporter and increased bile acid transport by 1alpha,25-dihydroxyvitamin D3 via the vitamin D receptor.
Chen X; Chen F; Liu S; Glaeser H; Dawson PA; Hofmann AF; Kim RB; Shneider BL; Pang KS
Mol Pharmacol; 2006 Jun; 69(6):1913-23. PubMed ID: 16481392
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo study of poly(ethylene glycol) conjugated ketoprofen to extend the duration of action.
Choi HK; Chun MK; Lee SH; Jang MH; Kim HD; Jung CS; Oh SY
Int J Pharm; 2007 Aug; 341(1-2):50-7. PubMed ID: 17517483
[TBL] [Abstract][Full Text] [Related]
19. Taurocholate transport by hepatic and intestinal bile acid transporters is independent of FIC1 overexpression in Madin-Darby canine kidney cells.
Harris MJ; Kagawa T; Dawson PA; Arias IM
J Gastroenterol Hepatol; 2004 Jul; 19(7):819-25. PubMed ID: 15209631
[TBL] [Abstract][Full Text] [Related]
20. Modulatory Effect of Theaflavins on Apical Sodium-Dependent Bile Acid Transporter (ASBT) Activity.
Takashima Y; Ishikawa K; Miyawaki R; Ogawa M; Ishii T; Misaka T; Kobayashi S
J Agric Food Chem; 2021 Aug; 69(33):9585-9596. PubMed ID: 34346218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
